原料词典检索/simmondsia-chinensis-seed-oil/SIMMONDSIA CHINENSIS SEED OIL
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
植物提取 (Plant)

SIMMONDSIA CHINENSIS SEED OIL

中国 NMPA《已使用化妆品原料目录 (IECIC)》: 未列入目录 (严禁自行机器翻译标示)
发用调理剂皮肤调理剂柔润剂
[EU CosIng Official Definition] Simmondsia Chinensis Seed Oil is the fixed oil expressed or extracted from seeds of the desert shrub, Jojoba, Simmondsia chinensis, Buxaceae
核心法规与安全结论 (Executive Fact Box)AEO / GEO CITATION ANCHOR

化妆品中 SIMMONDSIA CHINENSIS SEED OIL 的全球法规限值与配方应用标准是什么?

SIMMONDSIA CHINENSIS SEED OIL(CAS 号: 90045-98-0,未列入中国 IECIC 目录)是化妆品配方中主要用作发用调理剂, 皮肤调理剂, 柔润剂的核心成分。受中国 NMPA(未列管)、韩国 MFDS(未列管)及欧盟 CosIng(未列管)等 6 大法域法定标准监管,常规建议添加量为 1–6%(最佳稳定窗口 pH 4–8)。

全球 7 轨官方全成分标签名称对照表

严格采用各国政府官方目录原名 · 严禁机器翻译
7-Track Official Statutory Label Names for SIMMONDSIA CHINENSIS SEED OIL
法域与监管轨道官方公告全成分标准名称一键复制
① 韩国 (MFDS 化妆品标准名称)SIMMONDSIA CHINENSIS SEED OIL (KR MFDS Registered)
② 韩国旧名称历史 (301 重定向)——
③ 欧盟 (EU CosIng EC 1223/2009)SIMMONDSIA CHINENSIS SEED OIL
④ 美国普通化妆品 (US PCPC / MoCRA INCI)SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL
⑤ 美国 OTC 防晒/祛痘专论活性物名称 (FDA OTC)— (非美国 OTC 专论活性成分 / 普通化妆品原料)—
⑥ 中国 (NMPA《已使用化妆品原料目录 IECIC》标准中文名)未列入《已使用化妆品原料目录 (IECIC)》(严禁自行翻译标示)—
⑦ 日本普通化妆品 / 医药部外品 (JCIA / MHLW)SIMMONDSIA CHINENSIS SEED OIL (标准 INCI 参照)

Layer 1 — 全球 6 大法域法定限值与监管状态

Layer 1 Statutory Regulatory Limits Across 6 Regions for SIMMONDSIA CHINENSIS SEED OIL
法域监管状态法定限值适用条件与法定依据来源
韩国 (MFDS)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
欧盟 (EU)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
美国 (FDA)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
中国 (NMPA)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
日本 (MHLW)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
东盟 (ACD)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
⚠️ 仅供参考 (免责声明): 本词典中的原料名称、法规限值与配比指南仅供研发参考。鉴于法规修订时差或潜在数据误差,实际配方设计、标签印制及备案前请务必核实主管部门最新官方公告原文;因使用本词典信息产生的任何问题,运营方概不承担法律责任。
Interactive Quartile Box-Plot (Min–Q1–Median–Q3–Max)

Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit

Sunscreen / Colorn=5
Min 1% · Q1 1% · Median 4% · Q3 5% · Max 6%
Sunscreen / Color — Sun care & color cosmetics dispersion / sensory modifier
Verified Source: Global Starter Formulation Library Statistical Distribution (n=5, EVONIK 3 · GRANT 2) (cir_safety) · EVONIK 3 · GRANT 2
Typical Median: 4%

Layer 3 — 剂型常规配比指南与理化配伍性

Layer 3 Formulation Concentration Quartiles by Product Category for SIMMONDSIA CHINENSIS SEED OIL
剂型分类Min – Q1 – Median – Q3 – Max (%)配方作用与机理Source ID
剂型组 D — 防晒霜 / 彩妆 / 粉底1% · 1% · 4% · 5% · 6%Sun care & color cosmetics dispersion / sensory modifierGlobal Starter Formulation Library Statistical Distribution (n=5, EVONIK 3 · GRANT 2)
Cutaneous Permeation Science (500 Dalton Rule)MW: Macro/Complex · LogP: N/A

Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery

Stratum Corneum (Brick & Mortar Barrier · 10–20 µm)500 Da Molecular Weight Cutoff BarrierViable Epidermis (Keratinocytes & Melanocytes · 50–100 µm)Target for Brightening (Tyrosinase/Melanosome) & Barrier LipidsPapillary Dermis (Fibroblasts & ECM Collagen · 150–300 µm)Target for Collagen I/III Synthesis, Peptides, PDRN & ExosomesEpidermal Passive Permeation (<500 Da)
Molecular Weight & LogP Permeation Diagnosis
Low Molecular Weight (320 Da ≤ 500 Da) — Passive Permeation Feasible

Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.

Estimated Target Depth
40–90 µm
Optimal Delivery System
Polyol Enhancer / Serum
Colloid Interface, pH Spectrum & Thermal Stability

pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior

Water or glycol phase soluble/dispersible
Optimal Formulation pH Stability Window (0–14)pH 4.0 – 8.0
0245.5791114

Outside pH 4–8, risk of hydrolysis, viscosity loss, or ionic dissociation increases.

Maximum Thermal Processing Limit (°C)≤ 50°C
25°C45°C60°C75°C85°C100°C

Thermally stable up to 50°C during standard emulsification.

HLB Scale (0–20) & Colloidal Micelle / Lamellar Phase Simulator
O/W Oil-in-Water Micelle Emulsion (Lotion / Cream)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
Biochemical Signaling & Mechanism Pathway

Cellular & Molecular Target Mechanism Flow

1. Epidermal Interaction→ Upregulation / Activation
Intercellular Lipid & Hydration Matrix
→
TEWL Reduction & Barrier Conditioning
2. Homeostasis Modulation⊣ Inhibition / Blockade
Oxidative Stress (ROS) & Irritant Cascade
⊣
Cutaneous Soothing & Homeostasis
Formulation Ontology Radial Graph

Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)

+ GLYCERIN+ CAPRYLIC/CAPRIC TR…+ TOCOPHEROL✕ Verify phase compati…SIMMONDSIA CHINENS…
Interactive Node Guide

Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.

代表性商品名参考 (商标法第90条第1款第2项说明性标示)
SIMMONDSIA CHINENSIS SEED OIL

商品名仅供配方师识别原料规格参考,商标权归各原厂商所有。

学术与毒理综合摘要

Tier 1 Synthesis

本综述严格基于与该原料关联的 NIH PubMed 同行评审文献摘要及官方毒理学评估档案编写。

■ [1. Chemical Identity & International Labeling Nomenclature] - INCI Name: SIMMONDSIA CHINENSIS SEED OIL | CAS No.: 90045-98-0 | EC No.: 289-964-3 - Origin: PLANT | Functions: , , - Physicochemical Profile: Formula | MW /(Polymer/Complex) | / | Ionic Nature: non-ionic | CosIng/MFDS - Official Regional Label Names: US [SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL] · EU [SIMMONDSIA CHINENSIS SEED OIL] · CN [-] · JP [-] · JP Quasi-Drug [-] ■ [2. Dermatological Mechanism of Action & Functional Role] - Simmondsia Chinensis Seed Oil is the fixed oil expressed or extracted from seeds of the desert shrub, Jojoba, Simmondsia chinensis, Buxaceae Classified under origin 'plant', it acts within the cosmetic vehicle or stratum corneum to deliver , , performance and structural formulation stability. ■ [3. Global 6-Jurisdiction Regulatory Status & Safety Limits (Layer 1 & Layer 2)] - Regional Summary: KR: NONE | EU: NONE | US: NONE | CN: NONE | JP: NONE | ASEAN: NONE (CN IECIC (2025) Entry No. Unlisted (-)) - No specific Annex prohibition or numeric restriction across the 6 major jurisdictions (Permitted under general GMP safety assessment). - Official Safety & Historical Use Concentration (Layer 2): Quantum satis (QS) within standard cosmetic safety margins ■ [4. Formulation Dosage Guide by Product Category (Layer 3-A)] - [sun_color] Typical range: 1.0 ~ 6.0% (Median 4.0%, Ref: Global Starter Formulation Library Statistical Distribution (n=5, EVONIK 3 · GRANT 2)) — Sun care & color cosmetics dispersion / sensory modifier ■ [5. Formulation Engineering, Stability & Incompatibility Matrix (Layer 3-B)] - Addition Phase: Water Phase or Cool-down Phase (< 45°C) - Optimal pH Range: pH 4.0 ~ 8.0 | Max Process Temp: Max 50°C | Electrolyte Tolerance: MEDIUM - Incompatibility / Caution: Verify phase compatibility under extreme pH or high electrolyte loads - Synergy Pairings: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | Reference Trade Names: SIMMONDSIA CHINENSIS SEED OIL ■ [6. Peer-Reviewed Literature & Official Compendia Evidence] - PMID 41757774 (2026, J Craniofac Surg): A Translational Cell-Culture Study of Jojoba Oil: Potential Uses and Safety Considerations for Nasal Applications - PMID 23923639 (2013, Pharmazie): Evaluation of the mechanism of gelation of an oleogel based on a triterpene extract from the outer bark of birch

关联同行评审文献 (NIH PubMed) (2)

A Translational Cell-Culture Study of Jojoba Oil: Potential Uses and Safety Considerations for Nasal Applications [PMID: 41757774 · 2026]
S&#xfc;nnet&#xe7;i G, Bayar Muluk N, Acar TY, Bulbul MV, Keskin &#x130;, Alaskarov E, Cingi C · J Craniofac Surg (2026)

The effects of Simmondsia chinensis seed oil on human nasal epithelial cells were the focus of this investigation. Nasal epithelial samples were obtained from physiologically sound tissue, as is customary in septorhinoplasty. As soon as the nasal epithelial tissues were received in the laboratory, they were processed. To remove residual blood and potential microbiological contaminants, the specimens were washed multiple times with phosphate-buffered saline (PBS) containing a 2% (v/v) antibiotic-antimycotic solution. The tissue pieces were then concentrated by centrifugation. The effects of Simmondsia chinensis seed oil on cell viability were evaluated by quantifying cellular metabolic activity using the MTT colorimetric assay. Afterward, cells were exposed to Simmondsia chinensis seed oil at concentrations of 1, 5, 15, 25, 50, 75, and 100&#xa0;&#xb5;L per well for a continuous 24-hour incubation period. The inhibitory curve was well-defined in the quantitative dose-response model that used nonlinear regression. A logIC&#x2085;&#x2080; value of 0.8681 was used to compute the estimated half-maximal inhibitory concentration (IC&#x2085;&#x2080;), which was found to be 7.3 &#xb5;L. The high level of reliability and reproducibility in the association between oil exposure volume and the observed reduction in cell viability is supported by the strong model fit (R&#xb2;=0.9055). Analysis of metabolic activity in cells exposed to Simmondsia chinensis seed oil showed a strong inhibitory effect that increased with increasing oil concentration. Cell viability was expressed relative to untreated cells, which were assigned a reference value of 100%. A steady decline in viability was observed across the entire dose range evaluated, indicating that the oil's cytotoxic effects were strongly concentration-dependent. A statistical comparison was conducted to confirm these findings. The results showed that cell viability was significantly reduced at all tested exposure levels of Simmondsia chinensis seed oil compared with the negative control group. In addition, there was a strong dose-dependent cytotoxic effect, as statistical significance increased steadily with increasing exposure volumes. Ultimately, the viability and proliferation of nasal epithelial cells are reduced in a dose-dependent manner when exposed directly to Simmondsia chinensis seed oil. Nasal polyposis, granulation tissue formation after surgery, mucosal hyperplasia, and skin complications following rhinoplasty are among the otolaryngologic disorders that may benefit from the topical antiproliferative effects of Simmondsia chinensis seed oil. More clinical and experimental studies are needed to determine its therapeutic potential and safety profile before it may be used in clinical practice.

Evaluation of the mechanism of gelation of an oleogel based on a triterpene extract from the outer bark of birch [PMID: 23923639 · 2013]
Grysko M, Daniels R · Pharmazie (2013)

Oleogels are known for their high physical, chemical, and mechanical stability and good in vivo efficacy, which make them appropriate vehicles for dermal drug delivery and skin care for very dry skin. Modern formulation research focusses on well tolerated and sustainable formulation concepts. This paper deals with an innovative oleogel, which is based on a triterpene dry extract from the outer bark of birch (TE). In this formulation TE does not only act as an excipient but provides interesting pharmacological properties at the same time. The oleogel was formulated using solely Simmondsia Chinensis seed oil (jojoba oil) and TE. Fluorescence microscopy and confocal Raman microscopy showed that suspended TE particles arrange in a three-dimensional gel network. Infrared spectroscopy revealed that the formation of hydrogen bonds between TE particles is responsible for the self-assembly of TE in oil. Moreover, the influence of TE concentration and morphology of the TE particles on the viscoelasticity of the resulting oleogels was analyzed. Gel strength increased with TE concentration and was critical to the specific surface area of the TE particles.

常见问题解答 (FAQ)

Q1. SIMMONDSIA CHINENSIS SEED OIL 在全球 7 大法域的官方全成分标签名称是什么?
中国 NMPA《已使用化妆品原料目录 (IECIC)》标准中文名为 '未列入 IECIC 目录(严禁自行机器翻译)',美国 PCPC 与欧盟 CosIng 标准 INCI 为 'SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL',日本 JCIA 表示名称为 'SIMMONDSIA CHINENSIS SEED OIL'。
Q2. SIMMONDSIA CHINENSIS SEED OIL 在中、韩、欧、美、日、东盟的法定监管状态 (Layer 1) 如何?
6 大法域监管汇总 — 中国(CN): none,韩国(KR): none,欧盟(EU): none,美国(US): none,日本(JP): none,东盟(ASEAN): none。
Q3. SIMMONDSIA CHINENSIS SEED OIL 的常规配方添加量 (Layer 3) 与最佳稳定 pH 窗口是多少?
在代表性剂型 (sun_color) 中常规添加量为 1%–6%(中位数 4%),最佳稳定 pH 范围为 4–8。
Q4. SIMMONDSIA CHINENSIS SEED OIL 有哪些配伍禁忌 (Incompatibilities) 与协同增效组合?
推荐协同组合包括 GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL;配伍禁忌注意:Verify phase compatibility under extreme pH or high electrolyte loads。